Strides Pharma Science Ltd STAR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 872.30
- Day Range
- INR 865.00–875.45
- 52-Week Range
- INR 346.15–915.00
- Bid/Ask
- INR 868.55 / INR 869.20
- Market Cap
- INR 79.88 Bil
- Volume/Avg
- 24,586 / 335,649
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.04
- Dividend Yield (Trailing)
- 0.17%
- Dividend Yield (Forward)
- 0.17%
- Total Yield
- 0.17%
Company Profile
Strides Pharma Science Ltd is a specialty and generic drug manufacturer. The company focuses on developing niche and complex pharmaceutical products across therapeutic segments for regulated and emerging markets. Strides' emerging-market strategy focuses on branded generics for the treatment of chronic therapies. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 2,209
- Website
- https://www.strides.com
Comparables
Valuation
|
Metric
|
STAR
|
543434
|
524348
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 24.80 | 25.96 |
Price/Book Value | 3.84 | 4.03 | 3.44 |
Price/Sales | 2.04 | 5.57 | 1.75 |
Price/Cash Flow | 16.34 | 28.33 | 19.64 |
Price/Earnings
STAR
543434
524348
Financial Strength
|
Metric
|
STAR
|
543434
|
524348
|
|---|---|---|---|
Quick Ratio | 0.55 | 3.14 | 0.91 |
Current Ratio | 1.08 | 6.26 | 1.66 |
Interest Coverage | −0.05 | 192.48 | 8.03 |
Quick Ratio
STAR
543434
524348
Profitability
|
Metric
|
STAR
|
543434
|
524348
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | 7.10% |
Return on Equity (Normalized) | — | — | 13.89% |
Return on Invested Capital (Normalized) | — | — | 10.74% |
Return on Assets
STAR
543434
524348
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Khfrtygdf | Mwplvkg | $79.9 Bil | |
ZTS
| Zoetis Inc Class A | Wylktknlhh | Tnc | $79.3 Bil | |
HLN
| Haleon PLC ADR | Vptffvb | Skkng | $38.1 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Ljhtxjsr | Tcm | $18.9 Bil | |
VTRS
| Viatris Inc | Rwhfdng | Fwj | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Pfskywlqj | Qmyx | $11.7 Bil | |
CTLT
| Catalent Inc | Rjcwfvgc | Cftcqbn | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Vywkfjpm | Rtcpg | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Qlfbklydc | Xlqff | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Lsldvxdt | Pzfpyj | $3.2 Bil |